TY - JOUR
T1 - Discovery of Melanocortin Ligands via a Double Simultaneous Substitution Strategy Based on the Ac-His-DPhe-Arg-Trp-NH2 Template
AU - Todorovic, Aleksandar
AU - Lensing, Cody J.
AU - Holder, Jerry Ryan
AU - Scott, Joseph W.
AU - Sorensen, Nicholas B.
AU - Haskell-Luevano, Carrie
N1 - Publisher Copyright:
Copyright © 2018 American Chemical Society.
PY - 2018/11/21
Y1 - 2018/11/21
N2 - The melanocortin system regulates an array of diverse physiological functions including pigmentation, feeding behavior, energy homeostasis, cardiovascular regulation, sexual function, and steroidogenesis. Endogenous melanocortin agonist ligands all possess the minimal messaging tetrapeptide sequence His-Phe-Arg-Trp. Based on this endogenous sequence, the Ac-His1-dPhe2-Arg3-Trp4-NH2 tetrapeptide has previously been shown to be a useful scaffold when utilizing traditional positional scanning approaches to modify activity at the various melanocortin receptors (MC1-5R). The study reported herein was undertaken to evaluate a double simultaneous substitution strategy as an approach to further diversify the Ac-His1-dPhe2-Arg3-Trp4-NH2 tetrapeptide with concurrent introduction of natural and unnatural amino acids at positions 1, 2, or 4, as well as an octanoyl residue at the N-terminus. The designed library includes the following combinations: (A) double simultaneous substitution at capping group position (Ac) together with position 1, 2, or 4, (B) double simultaneous substitution at positions 1 and 2, (C) double simultaneous substitution at positions 1 and 4, and (D) double simultaneous substitution at positions 2 and 4. Several lead ligands with unique pharmacologies were discovered in the current study including antagonists targeting the neuronal mMC3R with minimal agonist activity and ligands with selective profiles for the various melanocortin subtypes. The results suggest that the double simultaneous substitution strategy is a suitable approach in altering melanocortin receptor potency or selectivity or converting agonists into antagonists and vice versa.
AB - The melanocortin system regulates an array of diverse physiological functions including pigmentation, feeding behavior, energy homeostasis, cardiovascular regulation, sexual function, and steroidogenesis. Endogenous melanocortin agonist ligands all possess the minimal messaging tetrapeptide sequence His-Phe-Arg-Trp. Based on this endogenous sequence, the Ac-His1-dPhe2-Arg3-Trp4-NH2 tetrapeptide has previously been shown to be a useful scaffold when utilizing traditional positional scanning approaches to modify activity at the various melanocortin receptors (MC1-5R). The study reported herein was undertaken to evaluate a double simultaneous substitution strategy as an approach to further diversify the Ac-His1-dPhe2-Arg3-Trp4-NH2 tetrapeptide with concurrent introduction of natural and unnatural amino acids at positions 1, 2, or 4, as well as an octanoyl residue at the N-terminus. The designed library includes the following combinations: (A) double simultaneous substitution at capping group position (Ac) together with position 1, 2, or 4, (B) double simultaneous substitution at positions 1 and 2, (C) double simultaneous substitution at positions 1 and 4, and (D) double simultaneous substitution at positions 2 and 4. Several lead ligands with unique pharmacologies were discovered in the current study including antagonists targeting the neuronal mMC3R with minimal agonist activity and ligands with selective profiles for the various melanocortin subtypes. The results suggest that the double simultaneous substitution strategy is a suitable approach in altering melanocortin receptor potency or selectivity or converting agonists into antagonists and vice versa.
KW - MC5R
KW - SAR
KW - alpha-MSH
KW - melanotropin
KW - selective ligands
UR - http://www.scopus.com/inward/record.url?scp=85047500997&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85047500997&partnerID=8YFLogxK
U2 - 10.1021/acschemneuro.8b00181
DO - 10.1021/acschemneuro.8b00181
M3 - Article
C2 - 29783840
AN - SCOPUS:85047500997
SN - 1948-7193
VL - 9
SP - 2753
EP - 2766
JO - ACS Chemical Neuroscience
JF - ACS Chemical Neuroscience
IS - 11
ER -